Condition: Head and Neck Squamous Cell Carcinoma · Patient Derived Organoid · Drug Sensitive Test in Vitro · Sponsor: Huashan Hospital
To evaluate the consistency of drug efficacy between the clinical systemic treatment and drug sensitive test based on patient-derived organoid in R/M HNSCC patients, using a prospective and multicenter observational study to increase the generalizability and reliability of research conclusion.
This description comes directly from the study's public registry record.
Lai-ping Zhong, MD, PhD · +862152888915 · zhonglp@hotmail.com
Tong-chao Zhao, MD, PhD · +862152889999 · 961497591@qq.com
Always discuss trial participation with your own doctor first.
| Huashan Hospital, Fudan University | Shanghai, Shanghai Municipality, China | Active Not Recruiting |
| Huashan Hospital, Fudan University | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06686342